Lou Hawthorne, NaNotics on Cleaning Blood with NanoparticlesRemoving inflammatory cytokines may be key to fighting many diseases.
ByArkadi Mazin November 4, 2022 0 Lou Hawthorne is the founder and CEO of NaNotics, a biotech company that creates nanoparticles that can soak up harmful molecules in circulation. This paradigm-shifting technology can be used to fight cancer as well as various inflammatory disorders, such as sepsis, which kills more people than cancer does. Other potential targets, familiar to everyone in the longevity field, are age-related sterile inflammation (inflammaging) and cellular senescence. Amazingly, Lou is an autodidact who earned his place in the field with his ingenuity and relentless pursuit of knowledge.What is your story? What was your journey to the longevity field?
Ann: Quarterly Reports - September 2022, page-76
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.87M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.6¢ | $15.87K | 963.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 3664858 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 2736651 | 6 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| ADN (ASX) Chart |